Agf Investments Inc. Bausch Health Companies Inc. Transaction History

Agf Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$21.6 - $27.79 $82,879 - $106,630	-3,837 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$23.0 - $29.01 $5,796 - $7,310	-252 Reduced 6.16%	3,837 $106,000
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $1,051 - $1,262	-42 Reduced 1.02%	4,089 $114,000
Q2 2021 Aug 10, 2021	SELL	$27.43 - $32.7 $306,502 - $365,389	-11,174 Reduced 73.01%	4,131 $121,000
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $225,667 - $363,052	10,560 Added 222.55%	15,305 $486,000
Q4 2020 Feb 08, 2021	SELL	$15.31 - $21.12 $1,745 - $2,407	-114 Reduced 2.35%	4,745 $98,000
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $5,654 - $7,649	-380 Reduced 7.25%	4,859 $76,000
Q2 2020 Aug 11, 2020	SELL	$13.31 - $20.51 $5,057 - $7,793	-380 Reduced 6.76%	5,239 $96,000
Q1 2020 May 08, 2020	BUY	$12.98 - $30.25 $72,934 - $169,974	5,619 New	5,619 $87,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.79B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.